11-77103266-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006189.1(OMP):c.427G>A(p.Val143Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,613,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006189.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OMP | NM_006189.1 | c.427G>A | p.Val143Ile | missense_variant | 1/1 | ENST00000529803.1 | NP_006180.1 | |
CAPN5 | NM_004055.5 | c.298-9323G>A | intron_variant | ENST00000648180.1 | NP_004046.2 | |||
CAPN5 | XM_011545225.1 | c.418-9323G>A | intron_variant | XP_011543527.1 | ||||
CAPN5 | XM_017018223.3 | c.406-9323G>A | intron_variant | XP_016873712.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OMP | ENST00000529803.1 | c.427G>A | p.Val143Ile | missense_variant | 1/1 | NM_006189.1 | ENSP00000436376 | P1 | ||
CAPN5 | ENST00000648180.1 | c.298-9323G>A | intron_variant | NM_004055.5 | ENSP00000498132 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000603 AC: 15AN: 248816Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135136
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461048Hom.: 0 Cov.: 34 AF XY: 0.0000289 AC XY: 21AN XY: 726832
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74310
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at